Found 225 matching trials
Statins in Patients With Spontaneous Intracerebral Hemorrhage
NAThe relation between improvement in results of treating spontaneous intrace...
Location
Pomeranian Medical University
Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia
PHASE2Dyslipidemia is an independent risk factor for cardiovascular events. Stati...
Location
the first affiliated hospital of Harbin medical university
High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV
PHASE2HILLCLIMBER is a randomized, controlled, open-label phase II trial of moder...
Location
Northwestern University
Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
PHASE4The goal of this study is to assess a slimy substance that settles/deposits...
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
PHASE4Investigators will study whether immediate statin treatment after the onset...
Location
Hyogo collage of Medicine
Influence of Organic Anion Transporting Polypeptide1B1(OATP1B1) Genotype on Rosuvastatin PK, PD and Lipid Profiles
PHASE4This study aimed to explore the influence of organic anion transporting pol...
Location
Clinical Trials Center, Seoul National University Hospital
Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography
PHASE4The study is a prospective, open-label, randomized, single-center study inv...
Location
Beijing Anzhen Hospital
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
NAStatins are the cornerstone of cardiovascular disease (CVD) prevention thro...
Location
Korea University ANAM Hospital
Rosuvastatin in African Americans With Cerebrovascular Disease
PHASE4This study will assess the rate at which rosuvastatin will achieve LDL targ...
Location
Detroit Medical Center
Effect of Genetic Variation on Efficacy and Safety of Lipid-Lowering Drugs
N/AThe primary end point was to reduce LDL-C levels by at least 50%, while the...
Location
Assiut University Heart Hospital